Transnational Drug Trafficking Act of 2015
PL 114-154 (S.32), enacted 05/16/2016

130 STAT. 387 
PUBLIC LAW 114–154—MAY 16, 2016 
Public Law 114–154 
114th Congress 
An Act 
To provide the Department of Justice with additional tools to target extraterritorial 
drug trafficking activity, and for other purposes. 
Be it enacted by the Senate and House of Representatives of 
the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Transnational Drug Trafficking 
Act of 2015’’. 
SEC. 2. POSSESSION, MANUFACTURE OR DISTRIBUTION FOR PUR-
POSES OF UNLAWFUL IMPORTATIONS. 
Section 1009 of the Controlled Substances Import and Export 
Act (21 U.S.C. 959) is amended— 
(1) by redesignating subsections (b) and (c) as subsections 
(c) and (d), respectively; and 
(2) in subsection (a), by striking ‘‘It shall’’ and all that 
follows and inserting the following: ‘‘It shall be unlawful for 
any person to manufacture or distribute a controlled substance 
in schedule I or II or flunitrazepam or a listed chemical 
intending, knowing, or having reasonable cause to believe that 
such substance or chemical will be unlawfully imported into 
the United States or into waters within a distance of 12 miles 
of the coast of the United States. 
‘‘(b) It shall be unlawful for any person to manufacture or 
distribute a listed chemical— 
‘‘(1) intending or knowing that the listed chemical will 
be used to manufacture a controlled substance; and 
‘‘(2) intending, knowing, or having reasonable cause to 
believe that the controlled substance will be unlawfully 
imported into the United States.’’. 
SEC. 3. TRAFFICKING IN COUNTERFEIT GOODS OR SERVICES. 
Chapter 113 of title 18, United States Code, is amended— 
(1) in section 2318(b)(2), by striking ‘‘section 2320(e)’’ and 
inserting ‘‘section 2320(f)’’; and 
(2) in section 2320— 
(A) in subsection (a), by striking paragraph (4) and 
inserting the following: 
‘‘(4) traffics in a drug and knowingly uses a counterfeit 
mark on or in connection with such drug,’’; 
(B) in subsection (b)(3), in the matter preceding 
subparagraph (A), by striking ‘‘counterfeit drug’’ and 
inserting ‘‘drug that uses a counterfeit mark on or in 
connection with the drug’’; and 
Transnational 
Drug Trafficking 
Act of 2015. 
18 USC 1 note. 
May 16, 2016 
[S. 32] 
VerDate Sep 11 2014 
06:31 Jul 18, 2022
Jkt 059194
PO 00001
Frm 00385
Fmt 6580
Sfmt 6581
G:\STATUTES\2016\PT1\59194PT1.001
59194PT1
dkrause on LAP5T8D0R2PROD with DISTILLER (1)
130 STAT. 388 
PUBLIC LAW 114–154—MAY 16, 2016 
LEGISLATIVE HISTORY—S. 32 (H.R. 3380): 
HOUSE REPORTS: No. 114–603, Pt. 1 (Comm. on the Judiciary) accompanying 
H.R. 3380. 
CONGRESSIONAL RECORD: 
Vol. 161 (2015): Oct. 7, considered and passed Senate. 
Vol. 162 (2016): May 10, considered and passed House. 
(C) in subsection (f), by striking paragraph (6) and 
inserting the following: 
‘‘(6) the term ‘drug’ means a drug, as defined in section 
201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
321).’’. 
Approved May 16, 2016. 
Definition. 
VerDate Sep 11 2014 
06:31 Jul 18, 2022
Jkt 059194
PO 00001
Frm 00386
Fmt 6580
Sfmt 6580
G:\STATUTES\2016\PT1\59194PT1.001
59194PT1
dkrause on LAP5T8D0R2PROD with DISTILLER (1)